12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
During Wednesday's pre-market session, several healthcare stocks experienced significant movements. NanoVibronix, Aravive, Dermata Therapeutics, AEON Biopharma, Akso Health Group, and Harvard Bioscience saw increases in their stock prices, while Outlook Therapeutics, FibroGen, OKYO Pharma, Tivic Health Systems, LENSAR, and Acorda Therapeutics experienced decreases.
August 30, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
FibroGen's stock declined by 24.61% to $0.96 during Wednesday's pre-market session.
The significant decrease in FibroGen's stock price indicates negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Outlook Therapeutics' stock decreased by 78.3% to $0.31 during Wednesday's pre-market session.
The significant decrease in Outlook Therapeutics' stock price indicates negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Aravive's stock moved upwards by 21.13% to $0.14 during Wednesday's pre-market session.
The significant increase in Aravive's stock price indicates positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
NanoVibronix's stock increased by 71.0% to $2.48 during Wednesday's pre-market session.
The significant increase in NanoVibronix's stock price indicates positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100